HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.

AbstractUNLABELLED:
Neutrophils from patients suffering from glycogen storage disease type Ib (GSD-Ib) show marked functional deficiencies (chemotaxis, respiratory burst, and phagocytosis). Here we describe neutrophil adherence receptor (L-selectin CD62L and beta2 integrins CD11b/CD18) deficiency in a patient with genotype of GSD-Ib, who presented with recurrent infections, diminished neutrophil count and impaired functions. Treatment with granulocyte-colony stimulating factor (G-CSF) had a beneficial effect on the infectious status, the enhancement of phagocytosis and the regression of the adherence receptor defect.
CONCLUSION:
this is the first observation of a patient with glycogen storage disease type Ib with a deficiency in leucocyte adherence receptor expression, which regressed with growth factor therapy. It underlines the potential role of these receptors in the genesis of recurrent infections which occur in patients with this disease.
AuthorsVéronique Latger-Cannard, Monique Marchand-Arvier, Michel Vidailhet, Jean Donadieu, Claude Vigneron, Pierre Bordigoni
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 161 Issue 2 Pg. 87-93 (Feb 2002) ISSN: 0340-6199 [Print] Germany
PMID11954758 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Granulocyte Colony-Stimulating Factor
Topics
  • Cell Movement (drug effects)
  • Chemotaxis, Leukocyte (drug effects)
  • Follow-Up Studies
  • Glycogen Storage Disease Type I (complications, diagnosis, drug therapy)
  • Granulocyte Colony-Stimulating Factor (administration & dosage)
  • Humans
  • Infant, Newborn
  • Leukocyte Count
  • Neutropenia (drug therapy, etiology)
  • Neutrophils (drug effects, physiology)
  • Prognosis
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: